SEARCH RESULT

Total Matching Records found : 520

Cropping Monsanto's patent rights -Vivian Fernandes

-The Financial Express The agriculture ministry is not reconciled to the grip which Monsanto has on the Indian cottonseed industry owing to the immense preference for its patented, genetically-modified (GM) bollworm-resistance traits. On May 16, Additional Solicitor-General Tushar Mehta intervened in a dispute between Monsanto and its biggest (now divorced) sub-licensee, Hyderabad-based Nuziveedu Seeds. He made written submissions on behalf of the government, a week after hearings on the matter had...

More »

What's in a generic name? -George Thomas & S Srinivasan

-The Hindu The core issues are affordable access to medicines and their rational prescription and use The Medical Council of India (MCI) issued a circular on April 21 drawing attention to clause 1.5 of its regulations regarding the professional conduct of doctors: “Every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription of drugs.” Further, the circular said,...

More »

Branded drugs need to be phased out: Doctors' groups

-The Times of India NEW DELHI: Doctors and public health groups have come together to suggest that the government should phase out branded drugs in a calibrated manner and ban differential pricing under different brands to promote generic drug prescriptions. This comes in the wake of PM Narendra Modi's announcement that the government was working on a legal framework to ensure that doctors mandatorily prescribed low cost generic medicines. Following the PM's...

More »

US places India yet again on IPR 'priority watch' list -Amiti Sen

-The Hindu Business Line Frowns on India’s IP laws; New Delhi unfazed, says laws are TRIPS-compliant New Delhi: Expressing its disappointment with India for not making adequate changes in its IP laws and regulations despite announcing its National IPR policy last year, the US Trade Representative’s (USTR) office has once again placed the country in the ‘priority watch’ list in this year’s edition of the Special 301 report. “Almost a year after the...

More »

Govt's generic push will dent Rs 90,000-cr branded pharma market -Veena Mani & Aneesh Phadnis

-Business Standard To make medicines cheaper, in another measure, govt added 200 drug formulations to NLEM list New Delhi/ Mumbai: Pharma companies may soon start wooing chemists as the Narendra Modi government plans to make it mandatory for doctors to prescribe pure-generic drugs, instead of branded generics as they do now. Though the plan was first announced in this year’s Budget, the prime minister spoke about it for the first time at a...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close